Current and future trends of acupuncture as an adjuvant therapy in cancer: A bibliometric and visual analysis DOI Creative Commons
Rui Shang, Ting Pan,

Fengyang Wang

et al.

Medicine, Journal Year: 2024, Volume and Issue: 103(29), P. e38663 - e38663

Published: July 19, 2024

Background: Acupuncture, as one of the representatives complementary therapies, is often used an adjunctive therapy in treatment cancer and related complications with beneficial results. Methods: We selected Web Science Core Collection (WOSCC) database data source searched to obtain relevant literatures on application acupuncture treatment. The literature was analyzed using CiteSpace (version 6.1.R6) VOSviewer 1.6.20). Results: A total 592 publications were included, overall upward trend number publications. There 135 countries or institutions involved, China most published country. 1888 institutions, Memorial Sloan Kettering Cancer Center institution 3067 authors there obvious collaborations between authors. 190 journals, J Clin Oncol cited journal. frequently occurring keywords breast management, but also other topics such quality life, chemotherapy, complementary. Conclusion: Acupuncture gaining increasing attention programs. Currently, research focuses alleviate cancer-induced comorbid symptoms, pain insomnia. Future gradually shifting toward spiritual care, Colorectal Surgery, systematic review.

Language: Английский

Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer DOI Creative Commons
Song Zeng, Xinlu Wang, Hua Yang

et al.

Military Medical Research, Journal Year: 2024, Volume and Issue: 11(1)

Published: Dec. 14, 2024

Abstract Ovarian cancer (OC) remains one of the most lethal gynecological malignancies globally. Despite implementation various medical imaging approaches for OC screening, achieving accurate differential diagnosis ovarian tumors continues to pose significant challenges due variability in image performance, resulting a lack objectivity that relies heavily on expertise professionals. This challenge can be addressed through emergence and advancement radiomics, which enables high-throughput extraction valuable information from conventional images. Furthermore, radiomics integrate with genomics, novel approach termed radiogenomics, allows more comprehensive, precise, personalized assessment tumor biological features. In this review, we present an extensive overview application radiogenomics diagnosing predicting tumors. The findings indicate artificial intelligence methods based accurately differentiate between benign malignant tumors, as well classify their subtypes. Moreover, these are effective forecasting survival rates, treatment outcomes, metastasis risk, recurrence patients OC. It is anticipated advancements will function decision-support tools managing while contributing precision medicine.

Language: Английский

Citations

4
Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort study DOI Creative Commons
Shohei Iyoshi, Mitsuhiro Sunohara, Masato Yoshihara

et al.

Japanese Journal of Clinical Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: March 20, 2025

Abstract Background In ovarian cancer (OvCa), achieving complete resection (RO) in initial surgery is crucial for improving prognosis. However, patients with undetected microscopic metastasis post-RO often have poorer outcomes. This study explores prognostic factors OvCa who underwent RO surgery, focusing on the role of ascites cytology as an indicator peritoneal metastasis. Methods We analyzed data from 975 cases Tokai Ovarian Tumor Study Group database (1986–2019). Excluding without chemotherapy or distant metastasis, we examined using Cox regression analysis. Propensity score (PS) methods balanced cytology-positive and -negative groups, subgroup analysis clinical stage volume. Results Multivariate identified FIGO III positive poor overall progression-free survival. After PS adjustment, also shortened intervals post-recurrence, especially lymph node Subgroup revealed a more substantial impact early-stage cases. Conclusion The present results suggest that R0 status, presence tumor cells independent negative factor may be micro-metastasis.

Language: Английский

Citations

0
Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer DOI Open Access
Paweł Kordowitzki,

Britta Lange,

Kevin M. Elias

et al.

CA A Cancer Journal for Clinicians, Journal Year: 2025, Volume and Issue: unknown

Published: April 19, 2025

Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of cancer, accounting for approximately 70% all cases contributing significantly to high mortality rates associated with this disease. Because asymptomatic nature early stage disease, patients are diagnosed at advanced stages when has already spread into abdominal cavity, requiring complex intensive surgical chemotherapeutic interventions followed by maintenance therapies. Although a minority well defined genetic syndromes, specific risk factors clear etiology in many remain elusive. HGSOC tumors characterized frequency somatic gene copy number alterations, often defects homologous recombination repair DNA. All attempts introduce an effective screening date have been unsuccessful. This review elucidates complexities surrounding encompasses its etiology, epidemiology, classification, pathogenesis, current array treatment strategies. Understanding molecular underpinnings crucial development targeted therapies personalized multimodal approaches centralized therapeutic structures. also examines importance tumor microenvironment. In addition, authors' objective underscore critical placing patient's perspective diversity forefront strategies, thereby fostering genuinely participatory decision‐making process ultimately improving patient quality life.

Language: Английский

Citations

0
Impact of Intraoperative Blood Transfusions on Survival Rates in Ovarian Cancer Patients DOI Creative Commons
Steven Benyahia, Monica Avila, Emily Coughlin

et al.

Cancer Control, Journal Year: 2025, Volume and Issue: 32

Published: April 1, 2025

Introduction Ovarian cancer remains a leading cause of gynecologic cancer-related mortality worldwide. Identifying perioperative factors that influence survival outcomes is essential for optimizing care. This study evaluates the impact such as intraoperative blood transfusions and hospital length stay (LOS) on rates in ovarian patients undergoing surgical debulking. Methods retrospective analyzed charts 314 who underwent surgery at single institution between 2010 2018. Patients were grouped based status: “Live” or “Death”. Variables included demographics, tumor size, comorbidity, anesthesia time, estimated loss, transfusion, readmission, length, survival. Statistical analyses log-rank tests mean estimations: chi-square Mann-Whitney U-test. Significance was set P < .05. Results The follow-up 50.5 months (95% CI, 47.8-53.2). Prolonged LOS (>3 days) significantly associated with reduced (47.4 vs 52.4 months, = .015). requiring had poorer (42.0 95% 36.3-47.7 53.1 50.3-55.9, .001). “Death” group experienced greater longer surgical/anesthesia times, higher fluid requirements. Conclusion stays are worse surgery. These findings underscore importance optimization strategies, including minimizing transfusion requirements reducing through enhanced recovery protocols.

Language: Английский

Citations

0
Overall survival in ovarian cancer patients after cytoreductive surgery. A systematic review and meta-analysis DOI

Qiaoying Chen

Current Problems in Surgery, Journal Year: 2024, Volume and Issue: 61(9), P. 101542 - 101542

Published: June 26, 2024

Language: Английский

Citations

3
Current and future trends of acupuncture as an adjuvant therapy in cancer: A bibliometric and visual analysis DOI Creative Commons
Rui Shang, Ting Pan,

Fengyang Wang

et al.

Medicine, Journal Year: 2024, Volume and Issue: 103(29), P. e38663 - e38663

Published: July 19, 2024

Background: Acupuncture, as one of the representatives complementary therapies, is often used an adjunctive therapy in treatment cancer and related complications with beneficial results. Methods: We selected Web Science Core Collection (WOSCC) database data source searched to obtain relevant literatures on application acupuncture treatment. The literature was analyzed using CiteSpace (version 6.1.R6) VOSviewer 1.6.20). Results: A total 592 publications were included, overall upward trend number publications. There 135 countries or institutions involved, China most published country. 1888 institutions, Memorial Sloan Kettering Cancer Center institution 3067 authors there obvious collaborations between authors. 190 journals, J Clin Oncol cited journal. frequently occurring keywords breast management, but also other topics such quality life, chemotherapy, complementary. Conclusion: Acupuncture gaining increasing attention programs. Currently, research focuses alleviate cancer-induced comorbid symptoms, pain insomnia. Future gradually shifting toward spiritual care, Colorectal Surgery, systematic review.

Language: Английский

Citations

0